Searching map area
A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer
? TBD
scientific article published on 28 April 2016
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Luigi Formisano
Mónica Valeria Estrada
Yisheng Li
Eric Winer
References
Wikidata